New noninvasive transcutaneous approach to blood glucose monitoring

Successful glucose monitoring on human 75 g OGTT with novel sampling chamber

S. Kayashima, Tsunenori Arai, M. Kikuchi, N. Sato, N. Nagata, O. Takatani, N. Ito, J. Kimura, T. Kuriyama, A. Kaneyoshi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

A novel noninvasive and quasi-continuous method of transcutaneous blood glucose monitoring for use with the human 75 g oral glucose tolerance test (OGTT) has been developed. The effused fluid was obtained by applying suction on the skin surface and labeled suction effusion fluid (SEF). The system consists of two main parts: a suction apparatus and the glucose sensor system. The suction apparatus applies vacuum to the patient's skin at 400 mmHg absolute pressure to collect the SEF. The miniature ion sensitive field effect transistor (ISFET) based glucose sensor can measure glucose in small SEF quantities. The monitoring system is based on the association between the glucose concentration in the SEF and in the serum. During the 75 g OGTT, the glucose change in the SEF was measured every 10 min. Although a response delay of up to 20 min was observed in the SEF glucose change, it was possible to perform the 75 g OGTT by this noninvasive monitoring method.

Original languageEnglish
Pages (from-to)752-757
Number of pages6
JournalIEEE Transactions on Biomedical Engineering
Volume38
Issue number8
DOIs
Publication statusPublished - 1991 Aug
Externally publishedYes

Fingerprint

Glucose
Blood
Sampling
Monitoring
Fluids
Glucose sensors
Skin
Ion sensitive field effect transistors
Vacuum

ASJC Scopus subject areas

  • Biomedical Engineering

Cite this

New noninvasive transcutaneous approach to blood glucose monitoring : Successful glucose monitoring on human 75 g OGTT with novel sampling chamber. / Kayashima, S.; Arai, Tsunenori; Kikuchi, M.; Sato, N.; Nagata, N.; Takatani, O.; Ito, N.; Kimura, J.; Kuriyama, T.; Kaneyoshi, A.

In: IEEE Transactions on Biomedical Engineering, Vol. 38, No. 8, 08.1991, p. 752-757.

Research output: Contribution to journalArticle

Kayashima, S, Arai, T, Kikuchi, M, Sato, N, Nagata, N, Takatani, O, Ito, N, Kimura, J, Kuriyama, T & Kaneyoshi, A 1991, 'New noninvasive transcutaneous approach to blood glucose monitoring: Successful glucose monitoring on human 75 g OGTT with novel sampling chamber', IEEE Transactions on Biomedical Engineering, vol. 38, no. 8, pp. 752-757. https://doi.org/10.1109/10.83587
Kayashima, S. ; Arai, Tsunenori ; Kikuchi, M. ; Sato, N. ; Nagata, N. ; Takatani, O. ; Ito, N. ; Kimura, J. ; Kuriyama, T. ; Kaneyoshi, A. / New noninvasive transcutaneous approach to blood glucose monitoring : Successful glucose monitoring on human 75 g OGTT with novel sampling chamber. In: IEEE Transactions on Biomedical Engineering. 1991 ; Vol. 38, No. 8. pp. 752-757.
@article{0b27c6f23c364d8dadf787e5d1465d8b,
title = "New noninvasive transcutaneous approach to blood glucose monitoring: Successful glucose monitoring on human 75 g OGTT with novel sampling chamber",
abstract = "A novel noninvasive and quasi-continuous method of transcutaneous blood glucose monitoring for use with the human 75 g oral glucose tolerance test (OGTT) has been developed. The effused fluid was obtained by applying suction on the skin surface and labeled suction effusion fluid (SEF). The system consists of two main parts: a suction apparatus and the glucose sensor system. The suction apparatus applies vacuum to the patient's skin at 400 mmHg absolute pressure to collect the SEF. The miniature ion sensitive field effect transistor (ISFET) based glucose sensor can measure glucose in small SEF quantities. The monitoring system is based on the association between the glucose concentration in the SEF and in the serum. During the 75 g OGTT, the glucose change in the SEF was measured every 10 min. Although a response delay of up to 20 min was observed in the SEF glucose change, it was possible to perform the 75 g OGTT by this noninvasive monitoring method.",
author = "S. Kayashima and Tsunenori Arai and M. Kikuchi and N. Sato and N. Nagata and O. Takatani and N. Ito and J. Kimura and T. Kuriyama and A. Kaneyoshi",
year = "1991",
month = "8",
doi = "10.1109/10.83587",
language = "English",
volume = "38",
pages = "752--757",
journal = "IEEE Transactions on Biomedical Engineering",
issn = "0018-9294",
publisher = "IEEE Computer Society",
number = "8",

}

TY - JOUR

T1 - New noninvasive transcutaneous approach to blood glucose monitoring

T2 - Successful glucose monitoring on human 75 g OGTT with novel sampling chamber

AU - Kayashima, S.

AU - Arai, Tsunenori

AU - Kikuchi, M.

AU - Sato, N.

AU - Nagata, N.

AU - Takatani, O.

AU - Ito, N.

AU - Kimura, J.

AU - Kuriyama, T.

AU - Kaneyoshi, A.

PY - 1991/8

Y1 - 1991/8

N2 - A novel noninvasive and quasi-continuous method of transcutaneous blood glucose monitoring for use with the human 75 g oral glucose tolerance test (OGTT) has been developed. The effused fluid was obtained by applying suction on the skin surface and labeled suction effusion fluid (SEF). The system consists of two main parts: a suction apparatus and the glucose sensor system. The suction apparatus applies vacuum to the patient's skin at 400 mmHg absolute pressure to collect the SEF. The miniature ion sensitive field effect transistor (ISFET) based glucose sensor can measure glucose in small SEF quantities. The monitoring system is based on the association between the glucose concentration in the SEF and in the serum. During the 75 g OGTT, the glucose change in the SEF was measured every 10 min. Although a response delay of up to 20 min was observed in the SEF glucose change, it was possible to perform the 75 g OGTT by this noninvasive monitoring method.

AB - A novel noninvasive and quasi-continuous method of transcutaneous blood glucose monitoring for use with the human 75 g oral glucose tolerance test (OGTT) has been developed. The effused fluid was obtained by applying suction on the skin surface and labeled suction effusion fluid (SEF). The system consists of two main parts: a suction apparatus and the glucose sensor system. The suction apparatus applies vacuum to the patient's skin at 400 mmHg absolute pressure to collect the SEF. The miniature ion sensitive field effect transistor (ISFET) based glucose sensor can measure glucose in small SEF quantities. The monitoring system is based on the association between the glucose concentration in the SEF and in the serum. During the 75 g OGTT, the glucose change in the SEF was measured every 10 min. Although a response delay of up to 20 min was observed in the SEF glucose change, it was possible to perform the 75 g OGTT by this noninvasive monitoring method.

UR - http://www.scopus.com/inward/record.url?scp=0026206278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026206278&partnerID=8YFLogxK

U2 - 10.1109/10.83587

DO - 10.1109/10.83587

M3 - Article

VL - 38

SP - 752

EP - 757

JO - IEEE Transactions on Biomedical Engineering

JF - IEEE Transactions on Biomedical Engineering

SN - 0018-9294

IS - 8

ER -